Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/23/25 21:19 | 1/21/25 | ABOS | Health | BioPrd | Biological Products, (No Diag | Zuga Matt | MA | O | CFO,Chie | 1 | S.m | -57 | 1.70 | 0 | -33 | 232 | D | |||||||||||||||
1/23/25 17:18 | 1/21/25 | ABOS | Health | BioPrd | Biological Products, (No Diag | Oconnell Daniel Joseph | MA | DO | CEO | 1 | S | -20 | 1.59 | 0 | -13 | 667 | D | |||||||||||||||
1/23/25 17:16 | 1/21/25 | ABOS | Health | BioPrd | Biological Products, (No Diag | Meisner Derek M | MA | O | GC,Corp | 1 | S | -5 | 1.59 | 0 | -3 | 161 | D | |||||||||||||||
1/23/25 17:14 | 1/21/25 | ABOS | Health | BioPrd | Biological Products, (No Diag | Barton Russell | MA | O | COO | 1 | S | -5 | 1.61 | 0 | -3 | 136 | D | |||||||||||||||
1/23/25 17:06 | 1/21/25 | ABOS | Health | BioPrd | Biological Products, (No Diag | Siemers Eric | MA | O | Chief Me | 1 | S | -5 | 1.59 | 0 | -3 | 170 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |